Merck & Co. is laying off 154 employees at its Durham, North Carolina facility. The company is ending production of Gardasil and Gardasil 9 at the site. This decision stems from a recent worldwide reduction in demand for the vaccine. The job cuts are scheduled to take effect on May 1. Merck continuously evaluates its business and adjusts operations as needed.
https://www.fiercepharma.com/manufacturing/merck-lay-nearly-150-staffers-research-triangle-area-vaccine-plant